Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 20713865

Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2010 Sep 20
First author
Cortes J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2011 Jan 20;29(3):e67-8; author reply e69. doi: 10.1200/JCO.2010.32.6751.
    note
    Source null
    related pmid
    21149649
    relationship
    Comment in

Authors and identifiers

  1. name
    Cortes J
    type
    Author
  2. name
    Moore JO
    type
    Author
  3. name
    Maziarz RT
    type
    Author
  4. name
    Wetzler M
    type
    Author
  5. name
    Craig M
    type
    Author
  6. name
    Matous J
    type
    Author
  7. name
    Luger S
    type
    Author
  8. name
    Dey BR
    type
    Author
  9. name
    Schiller GJ
    type
    Author
  10. name
    Pham D
    type
    Author
  11. name
    Abboud CN
    type
    Author
  12. name
    Krishnamurthy M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Cortes J
    type
    Author
  2. name
    Moore JO
    type
    Author
  3. name
    Maziarz RT
    type
    Author
  4. name
    Wetzler M
    type
    Author
  5. name
    Craig M
    type
    Author
  6. name
    Matous J
    type
    Author
  7. name
    Luger S
    type
    Author
  8. name
    Dey BR
    type
    Author
  9. name
    Schiller GJ
    type
    Author
  10. name
    Pham D
    type
    Author
  11. name
    Abboud CN
    type
    Author
  12. name
    Krishnamurthy M
    type
    Author
bibliography ids
  1. nci-bib-ead2b7d82fdf366eacf024c8
book metadata
content sha256
dd85d8d86459069cce7a1cff8520b17e5ed1679d50393af5d06d0cb1b4b3a591
document type
citation
dois
  1. 10.1200/JCO.2009.26.8896
electronic publication date
display
2010 Aug 16
precision
day
year
2010
evidence scope
bibliographic_metadata_only
id
pubmed:20713865
immutable id
pubmed:20713865@dd85d8d86459069cce7a1cff8520b17e5ed1679d50393af5d06d0cb1b4b3a591
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
27
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
4207-13
volume
28
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2011 Jan 20;29(3):e67-8; author reply e69. doi: 10.1200/JCO.2010.32.6751.
    note
    Source null
    related pmid
    21149649
    relationship
    Comment in
outcomes validated
false
pmid
20713865
provenance
batch id
10a38257e12e9ed1867a
provider
NCBI PubMed ESummary
record sha256
465c875337b566e538c5ad496a4ee53e401af292975db35dfe152c45eb4cdaf1
response sha256
84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
retrieved at
2026-09-09T23:46:35.793530+00:00
publication date
display
2010 Sep 20
precision
day
year
2010
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20713865/
title
Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study.

Preserved source evidence · Independent clinical review pending · Not medical advice